Research Collaboration Grants

Funding Agency:
American Brain Tumor Association

The ABTA Research Collaboration Grants are intended to promote team science in a way that will streamline and accelerate progress and effect the desired change in clinical outcome for brain tumors. The research projects supported under this mechanism must be conducted by a team of two co-principal investigators (Co-PIs) from distinct institutions. The research project should be multi-disciplinary in that it incorporates multiple components such as basic, translational, clinical, and epidemiological research.

By providing funding through its ABTA Research Collaboration Grants, the ABTA seeks to support multi-disciplinary high-risk/high-impact projects and promote collaboration to accelerate progress. These grants specifically encourage innovative research by allowing research teams to conduct the early scientific studies needed to secure additional/future funding for their collaborative projects. Additionally, investigators from sciences outside traditional biological fields are encouraged to apply. The development of new diagnostic and therapeutic approaches advances the understanding and treatment of brain tumors, and increases the potential for improving, extending and ultimately saving the lives of those living with a brain tumor diagnosis.

We seek projects focused on all brain tumor types, benign or malignant, primary or secondary (metastatic).

Deadline for Letters of Intent: Nov. 14, 2018

Agency Website

Eligibility Requirements

Applicant/Lead Principal Investigator

  • Must have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent
  • At the start of the grant term, applicants must hold a full-time faculty appointment (if applicant does not currently have a full-time faculty position, must have a formal offer letter at the time of full application submission showing a start date prior to the start of the grant term)
  • At the start of the grant term, Lead PI must have held a full-time faculty position or the equivalent for no more than 10 years (i.e. cannot have had a full-time faculty appointment before August 15, 2009)
  • Is not required to be a U.S. citizen or resident
  • Only one ABTA Research Collaboration Grant LOI can be submitted per Lead PI; however, individuals may serve as a Co-PI or contribute to more than one LOI
  • May concurrently apply for an ABTA Discovery Grant during the same grant cycle, but only one grant (either ABTA Research Collaboration Grant or Discovery Grant) will be awarded
  • May not be a PI on another ABTA grant at the start of the grant term

Co-Principal Investigator

  • Must have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent
  • At the start of the grant term, must hold a full-time faculty appointment at a distinct institution than the Lead PI (if Co-PI does not currently have a full-time faculty position, must have a formal offer letter at the time of full application submission showing a start date prior to the start of the grant term)
  • The Co-PI must make a specific time commitment to the project (the level of effort cannot be zero-0%)
  • Is not required to be a U.S. Citizen or resident

Lead PI and Co-PI Institutions

  • Lead Institution must be a non-profit institution or organization located in the US or Canada
  • Co-PI institution must be a non-profit institution anywhere in the world
  • Both the Lead PI and Co-PI Institutions must not be a governmental institution (i.e. NIH, NCI, etc.)
  • Lead Institution serves as the administrator of the Grant funds and will hold responsibility for the management of the budget and submission of all required documents and reports
  • Must agree to adhere to ABTA’s Policies and Procedures for Research Grants and Fellowships, located at the top of the ABTA Funding Opportunities webpage

Amount

$200,000

Amount Description

Grants are awarded for $200,000 in direct costs for two years. No indirect costs are allowed.

Funding Type

Grant

Eligibility

Faculty

Category

Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 14, 2018